Silvercrest Asset Management Group LLC Merck & Co., Inc. Transaction History

Silvercrest Asset Management Group LLC

  • $14.1 Billion
  • Q1 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 305,879 shares of MRK stock, worth $37.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
305,879
Previous 337,818 9.45%
Holding current value
$37.9 Million
Previous $36.8 Million 9.59%
% of portfolio
0.29%
Previous 0.27%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$113.24 - $131.95 $3.62 Million - $4.21 Million
-31,939 Reduced 9.45%
305,879 $40.4 Million
Q4 2023

Feb 14, 2024
SELL
$100.18 - $109.02 $67,421 - $73,370
-673 Reduced 0.2%
337,818 $36.8 Million
Q3 2023

Nov 14, 2023
SELL
$102.95 - $114.33 $241,829 - $268,561
-2,349 Reduced 0.69%
338,491 $34.8 Million
Q2 2023

Aug 14, 2023
SELL
$108.61 - $118.38 $47,245 - $51,495
-435 Reduced 0.13%
340,840 $39.3 Million
Q1 2023

May 15, 2023
SELL
$102.94 - $114.86 $402,289 - $448,872
-3,908 Reduced 1.13%
341,275 $36.3 Million
Q4 2022

Feb 14, 2023
SELL
$87.44 - $112.11 $234,863 - $301,127
-2,686 Reduced 0.77%
345,183 $38.3 Million
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $1.13 Million - $1.27 Million
-13,405 Reduced 3.71%
347,869 $30 Million
Q2 2022

Aug 15, 2022
BUY
$83.49 - $94.64 $887,498 - $1.01 Million
10,630 Added 3.03%
361,274 $32.9 Million
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $296,392 - $332,236
-4,032 Reduced 1.14%
350,644 $28.8 Million
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $587,491 - $735,909
-8,128 Reduced 2.24%
354,676 $27.2 Million
Q3 2021

Nov 15, 2021
SELL
$71.68 - $78.83 $2.18 Million - $2.4 Million
-30,385 Reduced 7.73%
362,804 $27.3 Million
Q2 2021

Aug 16, 2021
SELL
$70.31 - $77.77 $248,897 - $275,305
-3,540 Reduced 0.89%
393,189 $30.6 Million
Q1 2021

May 17, 2021
SELL
$68.86 - $81.11 $268,071 - $315,761
-3,893 Reduced 0.97%
396,729 $30.6 Million
Q4 2020

Feb 16, 2021
SELL
$71.77 - $79.65 $697,030 - $773,560
-9,712 Reduced 2.37%
400,622 $32.8 Million
Q3 2020

Nov 16, 2020
SELL
$73.18 - $82.95 $620,785 - $703,664
-8,483 Reduced 2.03%
410,334 $34 Million
Q2 2020

Aug 14, 2020
BUY
$70.42 - $80.13 $794,760 - $904,347
11,286 Added 2.77%
418,817 $32.4 Million
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $1.02 Million - $1.41 Million
-16,093 Reduced 3.8%
407,531 $31.4 Million
Q4 2019

Feb 14, 2020
SELL
$77.58 - $87.54 $734,294 - $828,566
-9,465 Reduced 2.19%
423,624 $38.5 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $34,464 - $37,567
-453 Reduced 0.1%
433,089 $36.5 Million
Q2 2019

Aug 14, 2019
SELL
$69.84 - $81.59 $137,864 - $161,058
-1,974 Reduced 0.45%
433,542 $36.4 Million
Q1 2019

May 15, 2019
SELL
$69.58 - $79.36 $468,621 - $534,489
-6,735 Reduced 1.52%
435,516 $36.2 Million
Q4 2018

Feb 14, 2019
SELL
$65.24 - $75.71 $717 - $832
-11 Reduced -0.0%
442,251 $33.8 Million
Q3 2018

Nov 14, 2018
SELL
$57.69 - $67.84 $672,780 - $791,150
-11,662 Reduced 2.57%
442,262 $31.4 Million
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $556,537 - $653,874
-10,949 Reduced 2.36%
453,924 $27.6 Million
Q1 2018

May 15, 2018
SELL
$50.96 - $59.23 $244,404 - $284,067
-4,796 Reduced 1.02%
464,873 $25.3 Million
Q4 2017

Feb 14, 2018
BUY
$51.62 - $61.64 $150,265 - $179,434
2,911 Added 0.62%
469,669 $26.4 Million
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $27.4 Million - $29.5 Million
466,758
466,758 $29.9 Million

Others Institutions Holding MRK

# of Institutions
3,766
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email